| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |